The Trans-Pacific Partnership--Is It Bad for Your Health?
Several leaked chapters of the Trans-Pacific Partnership Agreement indicate that it could have a substantial effect on health, largely by increasing the costs of medications in both low-income and high-income countries..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:373 |
---|---|
Enthalten in: |
The New England journal of medicine - 373(2015), 3, Seite 201 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kapczynski, Amy [VerfasserIn] |
---|
Links: |
---|
RVK: |
---|
doi: |
10.1056/NEJMp1506158 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1968375252 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1968375252 | ||
003 | DE-627 | ||
005 | 20220223153655.0 | ||
007 | tu | ||
008 | 160206s2015 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1056/NEJMp1506158 |2 doi | |
028 | 5 | 2 | |a PQ20160617 |
035 | |a (DE-627)OLC1968375252 | ||
035 | |a (DE-599)GBVOLC1968375252 | ||
035 | |a (PRQ)c1941-39701aa1fc050c1921ebffaa001d61d1237f44263a793cb578a180e46c055a460 | ||
035 | |a (KEY)0171808820150000373000300201transpacificpartnershipisitbadforyourhealth | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DNB |
084 | |a XA 10000 |q AVZ |2 rvk | ||
084 | |a 44.60 |2 bkl | ||
084 | |a 44.00 |2 bkl | ||
100 | 1 | |a Kapczynski, Amy |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Trans-Pacific Partnership--Is It Bad for Your Health? |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a Several leaked chapters of the Trans-Pacific Partnership Agreement indicate that it could have a substantial effect on health, largely by increasing the costs of medications in both low-income and high-income countries. | ||
650 | 4 | |a Drug Industry - legislation & jurisprudence | |
650 | 4 | |a Health Policy - legislation & jurisprudence | |
650 | 4 | |a Drug Costs - legislation & jurisprudence | |
650 | 4 | |a Commerce - legislation & jurisprudence | |
650 | 4 | |a Medical policy | |
650 | 4 | |a Management | |
650 | 4 | |a Laws, regulations and rules | |
650 | 4 | |a Public health | |
650 | 4 | |a Health care policy | |
650 | 4 | |a International trade | |
773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d Waltham, Mass. : MMS, 1928 |g 373(2015), 3, Seite 201 |w (DE-627)129495220 |w (DE-600)207154-X |w (DE-576)014893169 |x 0028-4793 |7 nnns |
773 | 1 | 8 | |g volume:373 |g year:2015 |g number:3 |g pages:201 |
856 | 4 | 1 | |u http://dx.doi.org/10.1056/NEJMp1506158 |3 Volltext |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26061752 |
856 | 4 | 2 | |u http://search.proquest.com/docview/1696913115 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_168 | ||
912 | |a GBV_ILN_183 | ||
912 | |a GBV_ILN_287 | ||
912 | |a GBV_ILN_290 | ||
912 | |a GBV_ILN_2004 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2012 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2219 | ||
912 | |a GBV_ILN_2414 | ||
912 | |a GBV_ILN_2424 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4219 | ||
912 | |a GBV_ILN_4256 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4310 | ||
912 | |a GBV_ILN_4315 | ||
912 | |a GBV_ILN_4320 | ||
912 | |a GBV_ILN_4323 | ||
936 | r | v | |a XA 10000 |
936 | b | k | |a 44.60 |q AVZ |
936 | b | k | |a 44.00 |q AVZ |
951 | |a AR | ||
952 | |d 373 |j 2015 |e 3 |h 201 |